TORONTO, ONTARIO--(Marketwire - February 07, 2008) - PharmEng International Inc. ("PharmEng") (TSX VENTURE: PII), a full-service consulting and contract manufacturing company, is pleased to announce that John Carkner is appointed the Keata Pharma President for the Arnprior manufacturing site. Keata Pharma is a wholly owned subsidiary of PharmEng with pharmaceutical contract manufacturing facilities in Ontario and new facilities in Sydney, Nova Scotia.
